Prechiasmatic Transection of the Unilateral Dodge Class I Optic Pathway Glioma without Neurofibromatosis Type 1: Technical Description and Clinical Prognosis

被引:0
|
作者
Li, Wensheng [1 ]
Li, Manting [1 ]
Luo, Lun [1 ]
Hu, Yuanjun [1 ]
Liu, Xuanxin [1 ]
Yang, Huasheng [2 ]
Guo, Ying [1 ]
He, Haiyong [1 ]
机构
[1] Sun Yat Sen Univ, Afliated Hosp 3, Dept Neurosurg, Guangzhou, Peoples R China
[2] Sun Yat Sen Univ, Zhongshan Ophthalm Ctr ZOC, Dept Eye Tumor & Orbital Dis, Guangzhou, Peoples R China
关键词
Optic nerve; Optic pathway glioma; Prechiasmatic transection; NERVE GLIOMAS; CHILDREN;
D O I
10.1016/j.wneu.2023.10.105
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
OBJECTIVE: For unilateral Dodge Class I optic pathway glioma (OPG-uDCI) without neurofibromatosis type 1, unilateral isolated optic nerve gliomas before the optic chiasm have been confirmed to possibly cause visual deterioration and poor prognosis. For this type of highly selective localized tumor, we explored surgery as the only treatment method. This article retrospectively analyzed and summarized the clinical data of this case series, with the aim of exploring the main technical details and clinical prognosis. - METHODS: Included were patients with OPG-uDCI without neurofibromatosis type 1 and experiencing vision loss on the affected side. The fronto-orbital approach was used, which was mainly divided into 3 parts: intraorbital, optic canal, and intracranial. All patients underwent prechiasmatic resection without any adjuvant treatments. The follow-up period was 3 months after surgery, and magnetic resonance imaging and contralateral visual acuity were reviewed annually after surgery. - RESULTS: All OPG-uDCI cases were completely removed without any adjuvant treatments, and there was no recurrence during the follow-up period. Pathological results showed that, except for 1 adult patient with pilomyxoid astrocytoma (World Health Organization grade II), the others all had pilocytic astrocytoma (World Health Orgaization grade I). Five patients experienced transient ptosis, and all recovered 3 months after surgery. CONCLUSIONS: For OPG-uDCI without neurofibromatosis type 1, radical prechiasmatic resection of the tumor is possible, without the need for postoperative radiotherapy and chemotherapy.
引用
收藏
页码:E648 / E654
页数:7
相关论文
共 50 条
  • [31] Clinical signs and genetic evaluation of patients with neurofibromatosis type 1 with and without optic pathway gliomas in a center in Turkey
    Parisa Sharafi
    Ali Varan
    Sibel Ersoy-Evans
    Sukriye Ayter
    Child's Nervous System, 2024, 40 : 511 - 515
  • [32] Clinical signs and genetic evaluation of patients with neurofibromatosis type 1 with and without optic pathway gliomas in a center in Turkey
    Sharafi, Parisa
    Varan, Ali
    Ersoy-Evans, Sibel
    Ayter, Sukriye
    CHILDS NERVOUS SYSTEM, 2024, 40 (02) : 511 - 515
  • [33] Manifestations and Treatment of Adult-onset Symptomatic Optic Pathway Glioma in Neurofibromatosis Type 1
    Mehlan, Juliane
    Schuettauf, Frank
    Salamon, Johannes M.
    Kordes, Uwe
    Friedrich, Reinhard E.
    Mautner, Victor-Felix
    ANTICANCER RESEARCH, 2019, 39 (02) : 827 - 831
  • [34] An Overview of Optic Pathway Glioma With Neurofibromatosis Type 1: Pathogenesis, Risk Factors, and Therapeutic Strategies
    Chen, Ying
    Yu, Jie
    Ge, Shengfang
    Jia, Renbing
    Song, Xin
    Wang, Yefei
    Fan, Xianqun
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2024, 65 (06)
  • [35] Identifying patients with neurofibromatosis type 1 related optic pathway glioma using the OMOP CDM
    Dhaenens, Britt A. E.
    Moinat, Maxim
    Didden, Eva-Maria
    Ammour, Nadir
    Oostenbrink, Rianne
    Rijnbeek, Peter
    EUROPEAN JOURNAL OF MEDICAL GENETICS, 2025, 75
  • [36] Optic pathway glioma and the sex association in neurofibromatosis type 1: a single-center study
    Henning, Anne Munk
    Handrup, Mette Moller
    Kjeldsen, Sia Mariann
    Larsen, Dorte Ancher
    Ejerskov, Cecilie
    ORPHANET JOURNAL OF RARE DISEASES, 2021, 16 (01)
  • [37] Insights into optic pathway glioma vision loss from mouse models of neurofibromatosis type 1
    Freret, Morgan E.
    Gutmann, David H.
    JOURNAL OF NEUROSCIENCE RESEARCH, 2019, 97 (01) : 45 - 56
  • [38] Reversible Growth Hormone Excess in Two Girls with Neurofibromatosis Type 1 and Optic Pathway Glioma
    Bruzzi, Patrizia
    Sani, Ilaria
    Albanese, Assunta
    HORMONE RESEARCH IN PAEDIATRICS, 2015, 84 (06): : 414 - 422
  • [39] Optic pathway glioma and the sex association in neurofibromatosis type 1: a single-center study
    Anne Munk Henning
    Mette Møller Handrup
    Sia Mariann Kjeldsen
    Dorte Ancher Larsen
    Cecilie Ejerskov
    Orphanet Journal of Rare Diseases, 16
  • [40] Current update on the visual outcome of optic pathway glioma associated with neurofibromatosis type-1
    Zeid, Janice Lasky
    FRONTIERS IN SURGERY, 2022, 9